Scott J. Weir, Pharm D, PhD


Scott J. Weir, Pharm D, PhD

Scott J. Weir, Pharm.D. Ph.D. is Director, Institute for Advancing Medical Innovation (IAMI), University of Kansas Medical Center (KUMC).  He also serves as the Associate Director for Translational Research for the University of Kansas Cancer Center.  Weir holds an academic appointment as Professor in the Department of Pharmacology, Toxicology and Therapeutics at KUMC, and is the Kelly Family Foundation IAMI Professor in Cancer Drug Discovery and Development. IAMI conducts product development-focused translational research, transforming laboratory and bedside discoveries into medical innovation products with clear paths to market. IAMI’s areas of focus are drugs, diagnostics and medical devices that benefit pediatric, adolescent, adult and elderly patients suffering from cancer and rare diseases. Weir has over 31 years of professional experience in the field of drug discovery and development, 20 of which were spent in the pharmaceutical industry prior to joining the University of Kansas Medical Center in 2006. He is co-inventor of a drug treatment for bladder cancer that is currently being developed by CicloMed LLC. His specific areas of expertise are in clinical pharmacology, pharmacokinetics and pharmacodynamics, biopharmaceutics, and developing innovative approaches to lead optimization and early drug development.  He has built a reputation of being innovative in bridging the “Valley of Death” through high performance public-private partnerships as well as repurposing approved drugs and rescuing abandoned drugs.

Take the steps you need to help change your prognosis.



Get free, timely information on living with an MPN.